Christopher Radchenko, MD
Pulmonary Disease · Cincinnati, OHNPI 1447547500
Payments from drug & device makers
Across 73 payments — averaging $158.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$4K
- Pinnacle Biologics, Inc$2K
- Intuitive Surgical$2K
- Pulmonx Corporation$843
- Johnson & Johnson$632
- Steris Corporation$474
- plus $1K from 7 others
What the payments were for
- Speaking & faculty fees$5,25045%
- Travel & lodging$1,41812%
- Food & beverage$4,88242%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 1 | $4,050 |
| Pinnacle Biologics, Inc | 13 | $2,395 |
| Intuitive Surgical | 24 | $1,947 |
| Pulmonx Corporation | 8 | $843 |
| Johnson & Johnson | 10 | $632 |
| Steris Corporation | 2 | $474 |
| Siemens Medical Solutions USA, Inc. | 2 | $324 |
| Veran Medical Technologies, Inc. | 3 | $263 |
| Boston Scientific | 4 | $181 |
| Olympus America Inc. | 3 | $151 |
| CSA Medical, Inc | 1 | $143 |
| AstraZeneca | 1 | $111 |
| Cook Medical LLC | 1 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,550 in reported general payments places this provider in the 75th percentile of 571 pulmonary disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $591 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Cincinnati
- Bruce CorserCincinnati$8.2M
- Jean ElwingCincinnati$2.4M
- Nishant GuptaCincinnati$1.5M
- Robert BaughmanCincinnati$1.1M
- Francis McCormackCincinnati$1.1M
- Mohammad SheattCincinnati$405K
- Robert BurkesCincinnati$299K
- Arun JoseCincinnati$287K
- Bruce TrapnellCincinnati$153K
- Rachel FootCincinnati$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.